Physician profile
John J Bruno
NPI 1447378401
$8,795.16
in general payments reported to CMS, 2019-2025
51 companies · $1,269 in 2025
The $1,269 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,184 · 2020: $425 · 2021: $561 · 2022: $438 · 2023: $561 · 2024: $1,357 · 2025: $1,269.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,087 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,087.47 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,642.90 | 2019-2025 | Rezum Generator, Lithovue |
| Abbvie INC. | $557.64 | 2019-2025 | Lupron Depot, Botox |
| Merck Sharp & Dohme LLC | $356.03 | 2020-2025 | Keytruda, Welireg, Lynparza |
| Amgen INC. | $354.12 | 2019-2022 | |
| Janssen Biotech, INC. | $280.70 | 2019-2025 | Erleada |
| Pfizer INC. | $262.69 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $237.06 | 2023-2025 | Gemtesa, Orgovyx |
| Novartis Pharmaceuticals Corporation | $234.91 | 2023-2025 | |
| Progenics Pharmaceuticals, INC. | $221.46 | 2021-2025 | Pylarify |
| Edap Technomed INC | $204.00 | 2024 | |
| Urogen Pharma, INC. | $199.92 | 2020-2025 | Jelmyto |
| Teleflex LLC | $181.72 | 2022-2025 | Barrigel, Urolift |
| Endo Pharmaceuticals INC. | $167.33 | 2020-2024 | Edex, Aveed, Xiaflex |
| Astellas Pharma US INC | $144.89 | 2019-2025 | Xtandi |
| Tolmar, INC. | $127.23 | 2024-2025 | Jatenzo |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Bruno listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.